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Preface 
 
In order to explore the convergence of bio- micro- and nano-technologies, three 
research institutes of the University of Twente organised a joint symposium 
entitled Integrated Micro Nano Systems: Convergence of bio and 
nanotechnologies. The purpose was to bring together research and business 
activities in the region to exchange information, with a view, amongst others, to 
preparation for the next EU framework programme for research and development.  
The keynote address was given by Dr. Andreas Lymberis of the European 
Commission. Three focus sessions were organized respectively by the three 
research institutes. The final session brought the keynote speaker together with 
representatives of the three research institutes to discuss a range of issues 
including future prospects and problems associated with innovation in this high 
tech multidisciplinary field. 
The symposium was organized by the CTIT e-health Strategic Research 
Orientation, in collaboration with MESA+ and BMTI and was held at the 
University of Twente, Enschede, The Netherlands, on 20 June 2006.  
The Centre for Telematics and Information Technology (CTIT) of the 
University of Twente researches various areas of ICT including embedded 
systems, smart sensor networks and Body Area Networks enabling biomedical 
applications. The MESA+ Institute for Nanotechnology conducts research in the 
fields of nanotechnology, microsystems, materials science and microelectronics, 
targetting different application domains including medical and life sciences. The 
research of the Institute for Biomedical Technology (BMTI) focuses on various 
(bio)medical technology issues from (early) diagnostics through medical 
intervention, cure, care and more rehabilitation related activities, including 
technologies for regenerative medicine.  
This volume contains the Proceedings of the Symposium. The Proceedings 
collect together the (extended) abstracts of the presentations and the descriptions 
of the demonstrations and posters. 
I would like to take this opportunity to thank all the participants who attended 
the symposium, and especially the speakers, session chairs and contributors of 
demonstrations and posters who made the content of the event so interesting and 
worthwhile. Thanks to the programme committee for their hard and diligent work, 
to the three institutes for supporting this event and to the logistics team who 
handled the practical arrangements so efficiently and effectively. 
 
 
 
http://www.ctit.utwente.nl/ 
http://www.mesaplus.utwente.nl/ 
http://www.bmti.utwente.nl/ 
 
Val Jones 
July 2006 
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Converging Micro-Nano and Biomedical Technology 
toward smart integrated systems: Vision, R&D and 
Future Challenges under the IST programme 
 
 
Andreas Lymberis 
 
European Commission, Information Society & Media Directorate-General1, 
Brussels, Belgium 
 
 
 
Introduction 
 
The whole sector of new technologies is dominated by two overriding trends. The 
trend towards miniaturisation (smaller structures with new properties and 
functions that need to be fed back again to the macro environment) and the trend 
of R&D interdisciplinarity. More and more technologies are finding their way into 
complex systemic products so that, apart from the development of individual 
technologies, the function of system integration is increasingly gaining in 
importance and constitutes a key to innovation and to industrial competition2.  
During the last years the area which originally started with MEMS (Micro-
Electro-Mechanical Systems) has grown into the area of Microsystems and Micro-
Nano Technologies already able to offer a broad range of solutions. This transition 
started during the 5th Framework Programme in which the IST Programme 
emphasized the industrial applications of these devices and MEMS and MOEMS 
(Micro-Opto-Electro-Mechanical Systems) devices shifted towards the notion of 
Microsystems (Fig. 1). In the 6th Framework Programme, the area progressed 
towards Micro and Nano Systems and towards using Micro and Nano Technology 
in different types of applications. 
Today, the R&D strategy and activities of Micro-Nano Systems, under the 
European Commission, Directorate General Information Society and Media, are 
based on three pillars:  
• Technologies and systems development e.g. MEMS, RF and 
communication microsystems, exhibiting very high integration and 
involving energy scavenging, plastic and organic micro-nano systems, 
displays and mass storage; 
                                                 
1 The views developed in this paper are that of the author and do not reflect necessarily the 
position of the European Commission. 
 
2 Micro-Nano Integration as a Key to Innovations, Dr Wolfgang Stoffler, German Federal 
Ministry of Education and Research. MANCEF: Commercialisation of Micro and Nano Systems 
Conference 2005 
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• Manufacturing and product innovation e.g. manufacturing tools and design 
tools development, laboratory to industrial environment transfer and new 
manufacturing processes; 
• Use of MNT and MNS to support applications e.g. automotive, home, 
health and biomedicine, robotics, food chain management, security and 
transport. 
 
 
 
Figure 1: Focus on Systems and Integration. 
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Micro-Nano Systems under the EC-IST Program: Current 
portfolio and research topics 
 
Throughout the Framework Programme 6 (FP6), the MNS area put strong 
emphasis on R&D for: 
• Improvement of cost-efficiency, performance and functionality of MNS 
and increased level of integration and miniaturisation allowing for 
improved interfacing with the surroundings and with networked services 
and systems;  
• Development, demonstration and preparation for industrialisation of 
emerging display technologies related to organic materials, lightweight 
near-to-the-eye information terminals and large size displays for the 
consumer; 
• Pushing the limits of integrated micro/nano systems through research on a 
family of mixed technologies (combining for instance micro-nano-
technology, ICT and biotechnology) and integration technologies for very 
high density or for integrating micro/nano devices into various materials 
and into large surfaces;  
• Validation of integrated micro/nano systems technology for new products 
and services in key application fields such as miniaturised autonomous 
robotic systems, mass storage systems and visualisation systems. 
In addition coordinating actions and specific support actions in collaboration with 
other thematic areas have been supported. The objective was to stimulate, 
encourage and facilitate the participation of organisations from the New Member 
States (NMS) and the Associated Candidate Countries (ACC) in the MNS 
activities. 
Specific foci in terms of technologies, systems and applications, were: 
• Technology and design of sensors, actuators, other devices, MST 
components, microsystems and the integration technology; 
•  Bio-sensors for Diagnosis and Healthcare; 
• Organic display technologies, advancing organic electronics and flexible 
technologies; 
• Heterogeneous technologies and devices for mixed-technology micro/nano 
systems (eg microfluidic/ICT/micro-nano, bio/ICT/micro-nano and 
chemical/ICT/micro-nano combined); 
• Technology for very high density hybrid integration (towards e-grains, e-
dust); 
• Smart textiles; 
• Validation and demonstration of networked micro/nano systems and their 
use to address problems and opportunities in a holistic manner combining 
device, system, information management and application competencies. 
Application sectors emphasized are environment, the home, food and 
agriculture and healthcare; 
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• Integrated systems and tools for point-of-care diagnosis, monitoring, and 
drug delivery; 
• Autonomous and miniaturised (micro-) robotic systems; 
• Roadmaps, specific coordination and support activities to prepare for a 
research agenda and to build the research community in order to define 
major trends and to address the ICT-bio-micro-nano-technology combined 
field. 
Major paradigm shifts have emerged, for example: 
• From single silicon devices towards a multitude of materials and integrated 
system; 
• From single disciplines to a very multi-disciplinary activity: physics, 
mathematics, chemistry, medicine, biotechnology, mechanics, micro-nano 
electronics, etc.; 
• From single technology devices driven development towards application-
pull integration of technologies depending of the maturity of the 
technology/device/system being developed. 
Particular emphasis during the last years is put on nanotechnology and its 
functional integration to build application environments. In this field the objective 
was to  push the limits of integrated micro-nano systems through research on a 
family of mixed technologies including research at the boundary and integration 
between different scientific and engineering disciplines e.g. micro-nano 
technology, ICT and biotechnology. Bio-medical and Bio-chemical areas have 
been identified as the most promising and growing after IT peripheral, by the 
NEXUS RoadMap.  
The table below shows the number of FP6 projects and the corresponding EC 
funding per application area. 
 
 
Number of 
Projects 
EC contribution 
(Millions €) 
Nano Bio ICT  24 101 
Micro- Nanosyst. for AmI         9 61 
Displays and Storage 13 49 
Sensor based systems 10 43 
Manufacturing / Proc. 
Integ.   10 31 
Support and Coordination         11 6 
TOTAL 77 291 
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Micro-Nano-Bio Systems 
 
MNS and integration towards healthcare/biomedicine and food safety/quality 
monitoring applications represents today 35% of the total MNS sector activities. 
Examples of the topics addressed by the projects are regrouped below. 
 
Biosensors, Lab on Chip, array sensors and other miniaturised MNS. 
These are enabling technologies for point of care, in vitro molecular diagnosis and 
biological analysis. Typical examples of projects are: OPTOLABCARD, aiming at 
the development of a quick and low-cost diagnostic device (Lab on a Card) that 
develops and integrates technology advances in optoelectronics, microfluidics and 
microbiology, capable to detect, in-situ, DNA pathogens in 15 minutes; 
BIOGNOSIS developing a uniquely integrated DNA and protein detection system 
for medical diagnostics, and BIOTEX aiming at the development of dedicated 
biochemical-sensing techniques compatible with integration into textiles; 
MASCOT an Integrated Microsystem for the Magnetic Isolation and Analysis of 
Single Circulating Tumour Cells for Oncology Diagnostics and Therapy Follow-
up; MICRO2DNA, an Integrated polymer-based micro fluidic micro system for 
DNA extraction, amplification, and silicon-based detection; LOCCANDIA, a Lab-
On-Chip based protein profiling for cancer diagnosis, and DVT-IMP, Deep Vein 
Thrombosis - Impedimetric Microanalysis System and GOODFOOD, aiming at 
the development of new micro-nano based analytical methods/systems for the 
detection of the presence of chemical substances (antibiotics, pesticides and 
mycotoxins) and live organisms (pathogens) in food, continuous control during 
lifetime and punctual monitoring, integrated under an Ambient Intelligence 
approach that will allow full interconnection and communication of multisensing 
systems.  
   
Body sensors, implantable MNS, endoscopic probes, active electrodes, micro-
nano robots 
These technologies enable biomedical monitoring, diagnosis, microanalysis, drug 
delivery, vigilance and stress support, etc. Representative examples are: 
NEUROPROBES, multifunctional microprobes for high temporal and spatial 
resolution brain studies, integrating advanced features such as microfluidic 
channels for drug delivery, fine depth control, telemetry, and biosensors to 
ultimately provide electrical recording and stimulation as well as chemical sensing 
and stimulation; VECTOR, a versatile Endoscopic Capsule for Gastrointestinal 
Tumor Recognition and Therapy, and P. CEZANNE, an implantable long-term 
nano-sensor for continuous BGL monitoring.  
 
Integration of micro-nano devices into textiles  
Another focus in FP6 was the integration of micro-nano devices into textiles 
including sensing, actuating, interfacing, power control, processing and 
communication. Four projects (which started at the end of 2005 and in 2006) 
comprise, for the time being, the cluster on smart textiles and flexible wearable 
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systems and applications: BIOTEX (biosensing textiles to support health 
management), CONTEXT (contactless sensors for body monitoring incorporated 
into textiles), PROETEX (Protection e-textiles: MicroNanoStructured fibre 
systems for Emergency –Disaster Wear), STELLA (stretchable electronics for 
large area applications). The integration of advanced fibres and materials at the 
fibre core, microelectronics components, user interfaces (e.g. sensors, displays, 
speakers), power sources and embedded software, make R&D extremely 
challenging. In addition, flexible systems and smart textiles should fulfill user 
needs and expectations in terms of user-friendliness, functionality, cost, fabric 
resistance and comfort. One of the challenges today is to fuse the research work 
and consumer insights on smart clothing and create multidisciplinary teams of 
product designers and engineers. The field is growing very rapidly in conjunction 
with the wearable electronics, platforms, networked sensors, etc.  
The above topics are very promising and mobilise significant resources in 
Europe and worldwide, for industry, research institutes and universities and open 
up the field for new converging technologies and emerging applications. 
 
 
Challenges and R&D directions for FP7 
 
The European Commission has organised several workshops to prepare future 
research areas1 with the contribution of key European stakeholders. 
MNS is part of a key challenge in FP7 i.e. to ascertain the EU’s position as a 
leading supplier of electronic components and systems in order to maintain and 
strengthen the competitiveness of its industrial strongholds. This includes areas 
such as automotive, avionics, industrial automation, consumer electronics, 
telecoms and medical systems where Europe’s leadership depends heavily on its 
capacity to master the design, production and integration of electronic components 
subsystems and systems.  
Research will deliver electronic and photonic components, micro/nanosystems, 
subsystems and embedded systems that are ever more complex and miniaturised as 
they converge with developments in nanotechnology and more recently 
biotechnology. It will enable the development of value chains that are more 
integrated than in the past, giving rise to complex multifunctional components and 
systems such as complete systems on chip (SoP) and systems in package (SiP).    
Among the major objectives, relating to MNS and BIO, for the next ten years are: 
                                                 
1
 Creating new opportunities from the marriage of micro-nano systems and Smart 
Fabrics & Interactive Textiles (SFIT), Brussels, 4 July 2005.  
Exploiting New Possibilities at the Interface of Micro-Nano Systems & the Living 
World, 5 July 2005, Brussels, Belgium,  
Micro-Nano-Bio Systems: Future R&D and New challenges, Brussels May 3, 
2006,  http://www.cordis.lu/ist/mnd/events.htm 
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• to progress in miniaturisation of chips and multi-functional components 
and to offer higher performance at lower cost and lower power 
consumption; 
• to improve integration, master complexity and add more functionality to 
the components, going towards SoP and SiP;  
• to master components based on new non-silicon materials and processing 
such as e-paper, large-area organic electronics and systems-on-foil which 
integrate sensing, processing and display functions leading to new markets;  
• to combine the multiple disciplines that are needed and the multitude of 
processes, materials and technologies required to design, manufacture and 
integrate miniaturised smart systems into all types of products and services. 
This includes miniaturised autonomous smart systems, new sensors, 
actuators and components for interfacing to biological systems like 
neuron/chip interfaces, as well as biochemical sensing on wearable 
platforms like textiles.  
Activities in the area of micro-nano-bio technology (MNBS) and integrated 
systems will also be addressed in the European Technology Platform on Smart 
System Integration (EPoSS) and are already included in its Strategic Research 
Agenda. Future activities in MNBS will target in particular:  
• new sensors and actuators to enable the development of new applications 
or to address new and old problems in a new manner;  
• multi-parameter biometrics and closed-loop functions, systems and devices 
enabling several applications; 
• devices with chemical and biological measurement features;  
• integration and packaging of heterogeneous components e.g. fluidic 
biosensors, radios, electronics and batteries in a cost-effective and reliable 
way; Lab on Chip, µTAS, DNA and protein arrays, BIOMEMS, smart and 
autonomous implant devices and biorobots; 
• multi-disciplinary education and applied engineering and research 
competencies to industry;  
• new business models to commercialise or to transfer research into 
innovation and markets.  
The spectrum of potential applications from the synergy of “nano-bio-info” 
technologies is very large, ranging from identification of genetic risk factors, early 
cancer recognition and treatment monitoring to applications in food and animal 
production, food safety, water safety and for environmental pollution screening. In 
conjunction with R&D, many issues such as regulatory and socioeconomic aspects 
e.g. interoperability, reimbursement and ethics, have to be rapidly addressed in 
order to stimulate further development and market opportunities. 
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Using Sensor Data in Smart Surroundings 
 
 
Maria Lijding 
 
Embedded Systems, University of Twente, The Netherlands 
lijding@cs.utwente.nl 
 
 
 
Abstract This paper motivates the need to use sensed data in Smart 
Surroundings and shows a few examples of how this data is currently 
being effectively used. The motivation stems from the settings of the 
Smart Surroundings project. Key to the settings is detecting context—
derived from physiological data, location, environmental data, agenda, 
social maps, etc.—and acting on the detected context, for example by 
adapting the ambience, determining access to privacy sensitive data, 
choosing between personal feedback or ambience feedback, etc. 
 
 
Smart Surroundings 
 
The overall mission of the Smart Surroundings project (http://www.smart 
surroundings.org) is to investigate, define, develop, and demonstrate core 
architectures and frameworks for future Ambient Systems. In this context, ambient 
systems are referred as networked embedded systems which support people in 
their everyday activities by integrating with the environment. They are aimed at 
creating a Smart Surrounding enabling people to increase their life standards and 
their productivity at work. These systems differ from traditional computing 
systems by being based on an unbounded set of hardware and software, which will 
be embedded in everyday objects or appear as new devices. 
One of the objectives of Smart Surroundings is to study ubiquitous computing 
in concrete and complex settings to ensure that development of platforms and 
foundations remains firmly grounded in reality. The project target is to design and 
implement real world experiments that expose ubiquitous computing systems to 
the challenge of supporting a multitude of competing applications and user 
experiences. 
We have decided to focus on two main settings: well-being and office. The 
focus on the well-being setting is stress management, while the focus on the office 
setting is flexible offices. As the reader may notice, both settings meet in the 
scenarios for stress management in the work environment. Additionally, a sub-
project—Home Care SenseNet—to improve elderly care began recently. Within 
the consortium work is also carried out in another setting for elderly care—Smart 
Medication System— but this will not be discussed here because of the potential 
for creating a product from it in the near future. 
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Key to the settings is detecting context—derived from physiological data, 
location, environmental data, agenda, social maps, etc.—and acting on the 
detected context, for example by adapting the ambience, determining access to 
privacy sensitive data, choosing between personal feedback or ambience feedback, 
etc. 
 
 
Settings 
 
Stress Management 
Stress is experienced by most people due to their work, sports, family 
responsibilities etc. People believe they can use some assistance in dealing with 
stress. Medically, stress is defined as a ”perturbation of the body’s homeostasis”.  
The common indices of stress include changes in (1) biochemical parameters (such 
as epinephrine and adrenal steroids), (2) physiological parameters such as 
increased muscle tension, heart rate and blood pressure and (3) behavioral effects 
such as anxiety, fear and tension. However, just as distress can cause disease, it 
seems plausible that there are good stresses that promote wellness. Stress is not 
always necessarily harmful. Increased stress at work for instance, may result in 
increase in motivation and awareness providing the stimulation to cope with 
challenging situations. However, long lasting periods of stress may result in 
negative stress. 
Excessive, prolonged and unrelieved stress can have a harmful effect on mental 
and physical conditions; for instance it is associated to cardiovascular diseases, 
immune system diseases, asthma and diabetes. Common signs of negative stress 
are tiredness, concentration and memory problems and changes in sleep patterns. 
People need to find an optimum balance between positive and negative stress. 
Since there is no single level that is optimum for all people, personal stress 
training systems can assist in reducing elevated levels of stress. Controlling stress 
by means of these systems contributes to the subjects’ well-being. Stress 
management should be individually adapted, able to learn from ongoing 
experiences, private, anywhere and anytime, active and continuously interacting 
with the surrounding to optimize feedback. This addresses the need for a wearable 
or private product (clothes, jewelry etc) so the subjects can and will be trained in a 
variety of settings which are not physically bounded. 
In the Smart Surroundings project the stress level is determined using different 
methods: measuring physiological data (e.g. muscle tension, heart rate), 
monitoring the user’s interaction with the environment (e.g. pressure exerted when 
using the mouse, playing with a pen or pressing a ball) letting the user provide 
feedback about his stress level with tangible interfaces, and taking into account the 
context of the user (e.g. room temperature, light level, activity performed, agenda, 
etc.). 
The feedback will be provided to modify the ambience (e.g. lights, sounds, music) 
where the user is at present (e.g. office, home, car), using wearable and private 
products as PDA, watches, jewelry, clothes, etc. Figure 1 provides a high-level 
view of the stress management setting. 
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Figure 1: Abstraction of the Stress Management setting 
 
Flexible Offices 
Nowadays, the trend for people to work in a more flexible way both while 
travelling to various locations and countries and within their own company 
building is apparent. Governments and employers have already started seeing 
advantages of flexible office solutions. It saves expenses of building maintenance, 
parking costs and reduces intensity of traffic and increases effectiveness of 
employees. This trend will continue in the future. Such a change will be motivated 
by economic reasons as well as by being a way to enhance the quality of work. 
Smart Surroundings envisions the future of office working as being different 
from what we experience today. Both the environment and the work itself will 
differ from today’s style of working. International cooperation and global 
activities of business, industry and research will involve more and more people 
working abroad. The mobility and temporary residence of working people 
promotes the idea of renting offices for short and mid-term periods instead of 
buying or continuously renting them. In this project, we picture the situation of a 
flexible office being rented for some weeks to some months for people who work 
abroad. This setting outlines requirements and possible solutions for such flexible 
offices. Special attention will be on the personalization of the office space as well 
as practical flexibility and usefulness of furniture and electronic equipment. 
Integrated Micro Nano Systems 
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People will start working in more flexible ways not only while traveling abroad 
but also within their own company building. A growing number of companies are 
switching to open work spaces and flexible working styles. An example of such a 
transformation is the Dutch insurance company - Interpolis. The biggest technical 
enabler for implementation of the flexible office concept was development and 
popularization of wide area networks, wireless communication and the Internet 
enabling remote access to the office. This change has an impact on technology as 
well as on the way teams work. 
Smart Surroundings believe that flexible offices will be part of our future. It is 
clear that if this is not correctly implemented, it can result in an undesirable 
environment for work. Therefore, the project is involved in providing a flexible 
and yet friendly and efficient way of working. We picture the situation of a 
flexible office, where no employee has his/her own, static office space. Every 
person has means to work from any place within a company building as well as 
from another location (client, home, etc.). The project outlines requirements and 
possible solutions for such flexible offices. Special attention will be paid to the 
communication aspect as well as to enablers for ad-hoc meetings. 
At present we are working on an abstraction called Mini-ME. Mini-ME is the 
user’s doublet in the working and family life, providing and receiving information 
around the worlds from/to other Mine-MEs, and giving to employees data needed 
in order to take decisions, organize time and get in contact with other people. 
Mini-ME will also allow the environment to be controlled and personalized to fit 
the preferences of the user, and the devices in the offices and outside them (e.g. 
coffee machines, copiers, overhead projectors) to be controlled. Other envisioned 
scenarios involve supporting workers to hold informal meetings in coffee rooms or 
corridors, and supporting formal meetings with unknown people. 
The Flex Office system offers a plethora of services to the inhabitants of the 
office. It can, for example, localize people and services within the office, and in 
this way provide appropriate information to the Mini-ME system. As nobody has a 
fixed place in the flexible office, it can be difficult to create a sense of personality 
in the office. Thus, the system can also execute personalized requests of a 
particular user in the office. 
An example of the services offered by the flex office is Smart Signs (Lijding et 
al, 2006). Smart Signs are a new type of electronic door- and way-sign based on 
wireless sensor networks. Smart Signs present in-situ personalized guidance and 
messages, are ubiquitous, and easy to understand. The Smart Signs system uses 
context information such as a user’s mobility limitations, the weather, and possible 
emergency situations to improve guidance and messaging. 
The following usage scenario is presented in the context of a fictitious Flex 
Office called TheNomads. 
TheNomads also offers a system of Smart Signs, which the employees can use 
at the doors of the office they occupy. The Smart Sign shows the name of a person 
working in a particular room and some information about where the employee 
currently is or when he is expected to be back. It can also show some personalized 
message addressed to a specific passer-by. 
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Martha is very often on the move and she often uses her Smart Sign to show a 
notice of ’I’ll be back in a moment’ whenever she goes to the toilet or to fetch 
coffee, or to get copies from the printer or office supplies. Whenever she is in a 
meeting the Smart Sign blinks frequently and shows the time the meeting is 
expected to finish. This is an advantage for Martha as she was never able to stay so 
long at her desk and her friends were complaining that she was unattainable. 
As she changes her offices so frequently, Martha never knows where the closest 
office facilities such as a printer are. The Smart Signs can collectively show to 
Martha the way to go to collect her prints. These are arrows projected in the 
direction of the printer; alternatively she can get the route on her personal 
handheld device. The signs can show the route to resources or people. When using 
a personal device, the system can also use audio as well as visual clues to indicate 
the way. 
Additionally the Smart Sign at the printer could show Martha when her 
printouts will be ready or what were the last documents it printed for Martha and 
when. 
 
Home Care SenseNet 
The Home Care SenseNet (HCSN) aims to improve quality of life for patients in 
need of care and for their care-givers. It achieves this by enabling longer 
independent living, and automating routine administrative task of care-givers. 
The strength of the HCSN is its simple deployment in existing private 
flats/houses and care institutions since no expensive cabling infrastructure is 
necessary. Sensor nodes can be attached exactly where they are needed and can 
last for years without maintenance. Small ad-hoc mesh WLAN nodes, which 
require only a power outlet, provide the second layer infrastructure connections 
that extend the lifetime and reach of the network in large buildings. The whole 
network is largely auto-configuring and requires no or little IT knowledge for set-
up and maintenance. 
The wireless sensor network will monitor a part of the physical environment, 
physiological state, and current location of clients and, optionally, of care-givers. 
The health-care application uses this context data to derive significant events, 
notify care-givers where appropriate, and log events for long-term analysis, 
administration, and accounting. Examples for significant events are “change diaper 
of client”, “client’s diaper was changed by care-giver”, or ”client sleeping 
uneasily”. In case of potential emergencies (e.g. “client may have fallen”), the 
HCSN will use the location information to alert the closest care-givers. A 
significant use case can be the recognition and monitoring of behavioural patterns 
and the detection of changes in that pattern. For example, the HCSN may monitor 
“normal” wake-up times, when which room is used in the house, at what times the 
fridge is opened or when medicine is taken.  
The actual events or parameters to monitor, acceptable form-factors for the 
sensors, and user interfaces to the health application are established in close 
cooperation with care givers and other users during the project. Important 
scientific challenges addressed in the project are to select the optimal, least 
invasive sensors, provide an auto-configuring and self-healing network while 
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enforcing security and privacy of sensitive data, and deriving high-level client-
related context using sensor fusion and inference. 
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Abstract At the University of Twente we have been researching 
mobile healthcare applications since 1999. Since 2002 the University 
of Twente and partners have been developing health Body Area 
Networks (BANs) and a BAN service platform. We define a BAN as 
a network of communicating devices worn on, around or in the body 
which provides mobile services to the user. The BAN may also 
communicate to remote users such as healthcare providers via 
external network services such as GPRS or UMTS. The generic BAN 
has been specialised for different mhealth applications targeted at 
different clinical conditions to provide a variety of telemonitoring 
and teletreatment services.  Each specialization of the BAN is 
equipped with a certain set of BAN devices and associated 
application components as appropriate to the clinical application.  
Despite the considerable R&D advances made in BAN and BAN 
service platform development, current technology means that it is not 
convenient for patients to tolerate wearing current generation BANs 
for long periods, amongst others because they have to wear or carry 
and manage a collection of different devices including a PDA or 
smart phone. However future and emerging technologies such as 
Ambient Intelligent Environments enabled by nano-technologies 
open the way for less obtrusive and more transparent systems and 
services. We envision increasing miniaturization enabling the 
“disappearing BAN” or AmI-BAN, incorporating micro- and nano-
scale devices, processes and materials, possibly implanted, 
communicating with the Ambient Intelligent Environment to provide 
cost-effective, unobtrusive, pervasive, context aware services (eg. 
detection, diagnosis, monitoring, treatment). Examples of some 
possible future AmI-BAN applications using micro-, bio- and and 
nano-technologies are presented. 
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Introduction 
 
The CTIT mhealth team at the University of Twente have been researching mobile 
healthcare applications (Jones et al, 1999; Jones, 2001) and Body Area Networks 
for trauma care and homecare (Jones et al, 2001) since 2001. Since 2002 we have 
been developing health Body Area Networks (BANs) (Konstantas et al, 2002) and 
a BAN service platform (van Halteren et al, 2003; Dokovsky et al, 2003). The first 
prototype was funded under the IST FP6 project MobiHealth (2002-2004), and 
development continues under the Dutch FREEBAND project AWARENESS and 
the European eTEN project HealthService24. In Mobihealth we combined the 
ideas of Body Area Networks (BANs), wireless communications and wearable 
devices (sensors, actuators...) to provide m-health services for patients and health 
professionals. The BAN service platform and a number of variants of the health 
BAN were trialled in 4 European countries, with various biosignals monitored and 
transmitted to remote healthcare locations over GPRS and UMTS. The nine 
clinical trials in MobiHealth included telemonitoring for cardiology and 
respiratory insufficiency (COPD) patients, for pregnant mothers and in trauma 
care.  
We define the generic BAN architecture as a network of devices, with an MBU 
(Mobile Base Unit) connected (by wireless or wired IntraBAN links) to a set of 
BAN connected devices. Sensors and actuators are examples of BAN connected 
devices. The MBU handles processing and is the gateway for Intra-BAN and 
ExtraBAN communication. Figure 1 shows one BAN configuration (for COPD 
patients). Here the MBU is implemented on a PDA (a Qtek) and this BAN is 
equipped with a respiration sensor and 3-channel ECG. Figure 2 shows the generic 
architecture of the MobiHealth BAN. 
 
 
 
 
Figure 1. COPD BAN       Figure 2.  Generic BAN architecture 
 
In the Awareness project development of the BAN and BAN service platform 
continues, with the main focus however on development of context aware BAN-
based m-health applications. The clinical applications currently being developed in 
Awareness are tele-monitoring (to detect epileptic seizures, and uncontrolled 
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movements in spasticity for spinal cord lesion patients) and tele-treatment (for 
management of chronic pain). 
The eTEN HealthService24 project also conducts further BAN development 
together with further development of the cardiology, COPD and pregnancy 
monitoring services. In preparation for commercialisation, HealthService24 
focuses on the business context of mhealth service provision. 
Over the course of these projects a range of BAN sensors have been deployed 
including: electrodes (for measurement of ECG and EMG), pulse oxymeter (to 
measure pulse plethysmogram and oxygen saturation), also respiration, 
temperature and activity (step-counter) sensors. Currently there are 35 BANs 
operational in 4 EU countries; the status of the system is a research system for use 
in medical trials (non-certified). 
The development team have made enormous progress in BAN and BAN 
service platform development, however current generation BANs have not yet 
reached desirable levels of unobtrusiveness and user friendliness, due to various 
limitations of current technologies. We envisage several directions in which BANs 
may evolve in the long term to overcome some of these shortcomings; in this 
paper we examine how future and emerging bio- micro- and nanotechnologies 
may enable health BANs of the future. Specifically three directions of possible 
future evolution are enabled by: 
• Wearable microelectronics  
• Implanted micro devices 
• bio-nanotechnology  
 
 
Wearable microelectronics 
 
With this direction of development we consider the components of the BAN 
(devices and communications channels) integrated into clothing or ‘body furniture. 
Much work has been done by the research community on development of smart 
textiles and integration of microelectronics into clothing, jewelry, spectacles and 
so forth. At Twente the BAN development team have experimented with 
incorporating the MBU into the Qbic belt computer.  In the European MOSAIC 
project and the under the Ami@Work initiative researchers at Twente also 
developed a future vision of BANs evolving into AMI-suits  for emergency 
services personnel in the context of major incident management (Jones & 
Saranummi, 2005). For example police uniforms would incorporate vital signs, 
audio-visual communications and positioning functionality in the textiles. In 
addition to these functions, firefighters’ suits would also incorporate 
environmental sensors to measure parameters such as external temperature, carbon 
monoxide and carbon dioxide levels. Paramedics’ uniforms would also be able to 
discover and query patient BANs and link BAN data with the electronic medical 
record. Audio-visual communications integrated into the paramedic uniforms 
would enable telepresence and augmented reality experience of the scene for 
hospital staff. Similarly disaster coordinators could benefit from remote viewing of 
the scene using the same technology (see Figure 3). 
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Fig. 3 AmIBAN integrated into emergency workers’ uniforms 
 
 
Implanted micro devices 
 
Medical implants (eg. pacemakers, prostheses, stents) have long been in routine 
use. With increased miniaturization many micro implants are being developed and 
some are already in use. One example is a sensor targeted at Congestive Heart 
Failure patients. The implanted sensor is “the size of a grain of rice” and can be 
used to measure pressure, flow, temperature or irradiation dosage. The device can 
also be used an activator for drug therapies or nerve or tissue stimulation. Acoustic 
waves are used for through-body communications and to energize the implant 
http://www.remonmedical.com/. Another example is an implanted neurostimulator 
for treatment of epilepsy, spasticity and movement disorders, chronic pain, 
profound hearing loss, incontinence or certain kinds of depression 
http://www.future-fab.com/documents.asp?d_ID=3725. 
For health BANs, the development of micro implants opens up the possibility 
of Intra Body Networks (IBNs), where BAN components are miniaturised and 
disappear inside the body. Not only  sensors and actuators, but one day perhaps 
also MBU functionality (computation, storage, communication) can be realised by 
implanted devices communicating wirelessly through tissue. Our generic BAN 
architecture should encompass this possibility, enabling integration of micro 
Vital signs 
Audio-visual comms 
Positioning 
Environmental sensors 
External temperature  
CO and CO2 
Flashover signs… 
Discover/query patient BANs 
Link BAN data with EMR 
Enable telepresence and  
            augmented reality  
            for hospital staff 
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implants into the BAN to create Intra-Body Networks. We have already discussed 
with clinical partners the possibility of using implanted sensors to give engineering 
feedback on performance of prostheses (eg. recording and transmitting real-time 
engineering data such as stresses and loads on artificial joints). Furthermore 
sensor–actuator coupling gives the possibility of utilizing close coupled feedback 
control loops. Some possible applications are: activation of implanted 
defibrillators for cardiac arrhythmia patients (eg. in long QT syndrome). Such 
devices are already in routine clinical use as standalone systems but could be 
components of a BAN or IBN. IBNs could also be used to tune power output of 
pacemakers after surgical implantation and for control of implanted medication 
pumps. 
 
 
Bio-nanotechnology  
 
Much further into the future we can anticipate BANs and IBNs which make use of 
various bio-nanotechnologies. One definition of Biotechnology is “Any 
technological application that uses biological systems, living organisms, or 
derivatives thereof, to make or modify products or processes for specific use” 
www.wfed.org/resources/glossary/ . The UK Institute of Nanotechnology define 
nanotechnology as "science and technology where dimensions and tolerances in 
the range of 0.1 - 100 nm play a critical role"1. Richard Feynman is credited with 
inventing the concept of nanotechnology in 1959, with the more specific concept 
of molecular machines (aka. molecular nanotechnology or molecular 
manufacturing). His concept was of a branch of engineering which deals with the 
design and manufacture of extremely small electronic circuits and mechanical 
devices at the molecular level of matter. Bio-nanotechnology can be defined as “a 
branch of nanotechnology based on using the biological structures such as 
proteins, ATP's, DNA, etc. as building blocks of nanoscale devices (e.g. 
nanomotors)” http://nanoatlas.ifs.hr/bio-nanotechnology.html. Bio-
nanotechnology may combine  biological (“wet”) components with engineered, 
synthetic (“dry”) components, and hence is also known as 'wet-dry' technology. 
By utilising or mimicking biological processes, bio-nanotechnology is, amongst 
other things, exploring how to replicate the fundamental operations of signal 
processing and signal transmission, computation and communication (which 
already occur in living systems) by manipulating bio-mechanisms at cellular and 
molecular scale.  
 
Molecular computing and molecular communications  
Molecular communications represent a convergence of nano- bio- and 
communications technology by allowing biological and artificial components to 
communicate. The sender encodes information onto a molecule, which is 
propagated to a receiver who decodes information and acts on it. Moore et al 
                                                 
1
 1 nanometer = 10-9 m, or one billionth of a meter.  
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(2006) discuss basic building blocks of computation and communication including 
molecular logic gates (eg. inverters and NAND gates), signal processing and 
transmission mechanisms, information encoding/decoding mechanisms, memory, 
mechanisms for  routing, addressing and relaying, both for single and multi hop 
communications. Moritani et al (2006) describe a communications mechanism 
where a microbead acts as an information molecule and is loaded onto a 
transporter molecule (a microtubule) which glides along a microlithographic track 
powered by biomolecular linear motor made of immobilised motor proteins. They 
propose DNA hybridisation as a means to load and unload information. 
 
 
Molecular devices 
Work is ongoing on nano-sensors; for instance Sasaki et al (2006) propose 
construction of a sensory device for selective detection of ‘biologically important 
molecules’ using amines as input signals, synthetic receptors, the enzyme LDH 
and a copper ion as mediator, the whole mounted on an (artificial) liposome cell 
membrane to provide a platform for integration of nano-components and 
communication between them. Moritani et al (2006) describe nano-scale 
actuators/effectors where a receiver reacts to a decoded signal, for example a 
captured molecule is introduced into a cell and produces biochemical reaction. The 
reaction may be to deliver drug or DNA to a targeted cell, to trigger altered 
morphology or cell movement or even gene expression.  
These three research groups see future applications in biomedicine and 
healthcare including nano-devices for metabolism control, energy conversion and 
information processing (Sasaki et al, 2006), Lab-on-a-chip (eg. for cell analysis or 
blood diagnosis) and implanted drug/DNA delivery systems (Moritani et al, 2006). 
For the latter they propose hormones as carrier molecules, delivered via endocrine 
pathways. One big advantage here and in general is that bio-nanotechnologies 
offer the promise of bio-friendly intervention. Moritani et al (2006) also envisage 
human body monitoring using implanted biochemical sensors to detect specific 
molecules (eg. allergens or viruses) and to perform functions such as physical 
check-ups and artificial control of immunoreactions.  
 
 
In Conclusion 
 
We see that the major functions of health BANs: sensing, actuating, signal 
processing, computation, information processing and communication are being 
researched or developed at nano-scale (albeit sometimes in very early stages of 
research). Nevertheless, this opens up the future possibility of the nanoBAN 
consisting partly or entirely of communicating implants and able to provide many 
kinds of monitoring, diagnostic, analytic and therapeutic services. Not only in vivo 
applications may be involved, also we can anticipate in the nearer future that in 
vitro micro and nanoscale devices (eg. Lab-on-a-chip for home use) may be 
integrated into, or communicate wirelessly with, current generation health BANs. 
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We can adopt this very futuristic concept as one of the long term visions driving 
our health BAN research. 
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Abstract There are many efforts today trying to mimic the properties 
of single cells in order to design chips that are as efficient as cells. 
However, cells are nature’s nanotechnology engineering at the scale of 
atoms and molecules. Therefore, it might be better to envision a 
microchip that utilizes a single cell as an experimentation platform. A 
novel so-called Lab-in-a-Cell (LIC) concept is described, where 
advantage is taken of micro/nanotechnological tools to enable precise 
control of the biochemical cellular environment and the possibility to 
analyze the composition of single cells.  
 
 
Introduction 
 
The understanding of many biological processes would benefit greatly from the 
ability to analyze the content of single cells. Today, there are only a few 
conventional systems available that enable direct intrinsic studies of single cells, 
including capillary electrophoresis, patch clamping and flow cytometry [1]. These 
systems, however, are based upon conventional technologies and instrumentation, 
give only limited information about the cell content and do not present a general 
method for single cell analysis. The recent rapid developments in micro-and 
nanofabrication technologies, which have already led to the successful so-called 
‘Lab-on-a-chip’ (LOC) concept, also open up great opportunities for analysis of 
single cells. 
The ‘Lab-on-a-chip’ (LOC) or ‘Micro Total Analysis Systems (µTAS) concept 
has received rapidly growing interest in the past ten years, as illustrated by several 
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review articles which go into more or less detail [2-6]. Initially, there were two 
approaches followed in this field, the first aiming at combining microsensors with 
fluidic components (pumps, flow sensors) into systems (e.g. ammonia/phosphate 
sensing) [7-8]. The second approach, which had a much greater impact, focused on 
miniaturization of analytical chemical methods, in particular separations, with 
(after the first demonstration with amino acids [9]) a lot of emphasis on genetic 
(DNA) analysis [10-13]. In Figure 1 an example of a lab-on-chip for genetic 
analysis is shown [13]. As genetic analysis has now become a more or less routine 
method, the new focus has been for some time, and still is, on using µTAS systems 
for protein analysis [3].  
 
 
 
 
 
Figure 1. (Top) Schematic of integrated device with two liquid samples and 
electrophoresis gel present. (Bottom) Optical micrograph of the device from 
above. Reproduced from [13] with permission. 
 
 
 
In addition, in the past few years, the interest in analysis of even more complex 
biological systems such as living cells with the use of microfabricated structures 
has attracted increased attention. A recent review illustrates the fact that 
microtechnologies are very useful for cell manipulation and analysis [14], and that 
they have advanced to a level that allows control of mechanical, electrical and 
biochemical parameters down to the nanometer scale. Most of the cited work 
derives from the past 5 years, with a clear trend towards single cell analysis, as 
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illustrated by the development of chip-based devices for single cell ion channel 
studies [15-17]. Although no reports of direct chemical analysis of single cells in 
microfluidic devices are known, Waters et al. have used microstructures for cell 
lysis, followed by PCR and capillary electrophoresis (CE) for analysis of the DNA 
of cells [18]. Nevertheless, cell analysis even without need for amplification seems 
only to be a question of time, as recently new approaches to single cell analysis by 
CE have been proposed by Zabzdyr et al., albeit in a conventional system [19].  
It is clear that with the recent technological developments many life-science 
researchers obtain very powerful tools for detailed cellular studies [20]. The novel 
concept, Lab-In-a-Cell (LIC), described in this article intends to combine the best 
of both worlds by using the biological “unit” - a cell - as a laboratory in which to 
perform complex biochemical operations, and by using advanced micro- and 
nanotechnological tools to access and analyze this laboratory and interface it with 
the outside world. This idea of combining efficient and specific functioning, 
generated by “natural” structures, with man-made micro/nanofabricated devices 
has similarities with other examples such as the use of the natural ionophores (e.g. 
the antibiotic valinomycin) to create highly selective ion sensors [21], entrapment 
of enzymes such as glucose oxidase for obtaining a micro-glucose sensor [22], or 
utilization ion-channel proteins (e.g. α-hemolysin) incorporated in lipid bilayers 
for single molecule DNA sequencing [23], as well as in the concept of cell-based 
sensors by [24]. The LIC concept, however, aims at exploiting the incredible 
complexity and effectiveness of individual cellular processes in a much broader 
scope, as we will illustrate below.  
 
 
Concept 
 
In biological systems, such as single cells, the parallel handling of small numbers 
of molecules is inherent. A differentiated eucaryotic cell can perform some 103-
104 different chemical operations simultaneously, depending on the protein 
content, at overall burning rate of 106 molecules/s of ATP [25]. All this is 
performed in a volume element in the order of 1 picoliter. How is this chemical 
multiprocessing capability in extremely small volumes possible? Part of the 
solution to this question is found in five main features: 1) compartmentalization 
(i.e. the usage of specialized reaction containers such as organelles with volumes 
of 10-15-10-21 liter, with controlled input and output properties), 2) molecular 
recognition (highly specific interactions between reacting molecules or binding 
interactions in a sorting/counting step), 3) a combination of small scale and 
complex function, 4) targeted transport and controlled mixing of components (for 
example by the use of vesicles as cargo carriers between organelles) [25], 5) 
preservation of internal laboratory conditions. There are many efforts today trying 
to mimic these properties of single cells in order to design chips that are as 
efficient as cells. We believe it might be better to take advantage of the optimized 
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natural “laboratory” represented by a cell and to envision a chip where a single 
cell constitutes the core, a Lab-In-a-Cell. 
Imagine that today’s life science laboratories are represented by single cells on 
chip. Then you would need several different components on the chip in order to 
put your ‘lab’ on a specific position on the chip, to study what is going on inside 
the ‘lab’, to deliver and/or withdraw data from it (see Figure 2). Hence, for the 
new LIC concept the following functions have to be provided: 
• Cell manipulation/immobilization 
• Electrical/mechanical/biochemical/optical characterization 
• Connection/communication external/internal 
 
 
 
 
 
Figure 2. Conceptual drawing of the lab-in-a-cell concept. 
 
 
In the literature up to the present a few examples have been presented for single 
cell analysis on chip [26]. In figure 3, one example of LIC is shown; here single 
cells are trapped on chip and enable real time studies of apoptosis which is not 
possible today with the conventional technologies [27]. 
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Figure 3. A single cell trap for real time studies of cellular processes [27]. 
  
 
Discussion 
 
Populations of cells have been used as ‘workhorses’ for producing biological 
compounds or as sensing elements since the beginning of 20th century. However, it 
has not been possible to access and make use of the processes of individual cells 
due to the lack of tools able to operate on and interact with individual cells. New 
micro/nanotechnological tools have now opened new opportunities for realizing 
novel biochemical/mechanical/optical-characterization methods of single cells. 
Possible applications of LIC systems are for example 1) detailed studies of 
intracellular processes and mechanisms, e.g. detecting ion-channel responses as 
function of external stimuli, 2) use of single cells as nanoreactors for 
combinatorial chemistry, 3) use of single cells as platform for drug testing (thereby 
reducing the need of animal testing) and 4) the development of single cell based 
sensors etc. 
Hopefully, this article promotes awareness among biologists that single cells 
can be considered as experimental platforms, as well as acting as a stimulus for 
micro/nano engineers to further develop and refine the needed instrumentation. 
 
 
Conclusion 
 
Currently much effort is being put into trying to mimic the properties of single 
cells in order to design chips that are as efficient as cells. However, cells are 
nature’s nanotechnology engineering at the scale of atoms and molecules and it 
will be very difficult (impossible) to create lab-on-chips that are as efficient as 
cells. Therefore, it might be better to envision chip solutions where a single cell 
constitutes the core, the workhorse, and the chip is the interface that enables 
manipulation, characterization and communication.  
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Abstract In an era of aging populations and rising health-care costs, 
the shift of medical paradigms towards rapid, accurate, early 
diagnoses of diseases is inevitable. In addition to further development 
of ultrasensitive in vitro tests, the focus of attention in both 
diagnostics and the early drug discovery process is increasingly 
trained on the cell. The immense complexity of biological processes in 
disease requires developing enabling tools and technologies capable of 
rapid, dynamic imaging of high-content information with high spatial 
and temporal resolution. This enterprise automatically requires cross-
cutting multidisciplinary teams that can integrate advanced imaging 
and detection technology, fundamental biological and biochemical 
knowledge, bioconjugate chemistry, nanotechnology and advanced 
image processing and data storage. Below I present a short summary 
of key enabling technologies currently in use or in development, and 
explore challenges for the future. 
 
 
Introduction 
 
The grand challenge of contemporary healthcare is to impact the efficiency of 
delivery and the cost of the care process by addressing compelling biomedical 
questions and unmet clinical needs. One key paradigm is the so-called “find, fight, 
follow” approach; this paradigm essentially breaks the care process down into the 
stages of diagnostics, therapy and follow-up care. The focus is increasingly 
moving towards early events in the care cycle, with a particular emphasis, where 
possible, on detection of disease before the onset of symptoms. The socio-
economic impact of early detection is immense, and can have a fundamentally 
disruptive effect on the costs and provision of health care. 
The scientific challenge for diagnostics is the need to measure 
• Specific biomarker and/or intermolecular interactions 
• In a complex, heterogeneous medium (blood, serum, cells) 
• At low concentrations 
• With high spatial and temporal fidelities. 
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The diagnostic and measurement targets include 
• Rare or diseased cells 
• Viruses and bacteria 
• Protein-nucleic acid, protein-protein, or receptor-ligand interactions 
• Ligands and metabolites. 
The diagnostic challenge is one that spans a range of length scales, from that of 
a single molecule (~nanometers) to that of the cell (~ microns). Tools and 
techniques need to be developed that are in principle able to address these very 
different length scales, in the complex context of cells. There is a pressing need to 
be able to measure more than one analyte or event at a time. Thus, the challenge is 
to provide key information with respect to the biology of the target, and its 
surrounding context. Although the push towards single analyte or single cell 
analysis is an important factor in the context of ultrasenstive early diagnostics, the 
intrinsic variability of biology also requires that multiple measurements can be 
made easily and effectively to provide the requisite statistics for reliable 
conclusions. 
 
 
An Integrated Strategy 
 
The challenge of making systematic, specific, and sensitive diagnostic 
measurements for early diagnostics requires an integrated strategy unifying the 
development of enabling technologies, innovative research tools, and smart data 
handling and analysis. All three components are key to devising point of care 
solutions for early diagnostics of disease. 
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Nanotechnology and advanced biomedical instrumentation and methods are 
playing, and will continue to play, an essential role in making a success of such an 
integrated strategy. 
The enabling technology drivers of such a unified approach include: 
• High throughput visualization methods 
• Automated multiparameter microscopy enabling quantitative measurement 
of multiple targets and processes 
• Combinations of microscopy and spectroscopy yielding functional 
microscopies 
• Advanced approaches such as fluorescence lifetime and polarization 
methods in imaging to provide insights into the mechanisms of processes 
• Hybrid microscopy methods (such as combinations of scanning probe and 
optical microscopy) 
• Cell handling methodologies incorporating aspects of patterning and 
nanostructuring of biocompatible surfaces, (micro)cytometry, 
microfluidics, and micro- and nano-manipulation of individual cells. 
Innovative research tools are revolutionizing the ability to quantitatively 
visualize and measure multiple specific biological processes in cellular systems. 
These tools include: 
• Nanotechnology-based contrast agents for imaging and therapy, including 
o Semiconductor nanocrystals (quantum dots) 
o Gold and silver nanoparticles 
o Magnetic nanoparticles 
• Genetically encodable probes, such as 
o Visible fluorescent proteins 
o Specifically addressable peptide recognition sequences and tags 
• Novel small molecule probes for fluorescence, Raman, absorbance, MRI 
and PET scanning 
• New and efficient bioconjugation strategies to link these probes to 
biological targets 
• Targeting and delivery strategies to get the biosensor to the site of disease 
or incipient disease. 
Finally, all of these techniques will yield a vast quantity of data that needs to be 
rapidly and reliably analyzed, preferably online, to deliver a clear readout enabling 
a therapeutic decision to be made. 
 
 
Summary 
 
The key task for the coming years is to leverage the enormous advances in 
sensitive molecular imaging techniques, biophysics, new research tools, and data 
management and analysis to 
• Yield quantitative high-content biology 
• Better understand fundamental cell processes and biophysics 
• Enable rapid, inexpensive diagnostics 
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• Better understand mechanisms of disease and pharmaceutical specificity 
• Enable specific targeted therapy. 
Rapid advances in areas such as regenerative medicine will also require us to 
rethink our current models for diagnosis and deal with the complexities of three-
dimensional cell culture and tissue. We will have to continue to develop new tools 
to address the unique problems associated with these complex 3-D systems to 
provide diagnostic capabilities for the new millennium. 
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Abstract Oxide materials exhibit a wide range of functional 
properties, such as isolators, superconductors, ferromagnets and 
ferroelectrics. This diversity in materials properties opened the very 
active research area of “oxide electronics”. Nowadays, it is possible to 
control the growth of oxide thin films with atomic precision and these 
oxide films start to play a very important role in electronic devices.  
Recently, a new “degree of freedom” has been recognised. By 
atomic control of interfaces between oxide materials, i.e., the chemical 
composition and crystalline structure, new phenomena can be 
observed. One example is the electronically conducting interface 
between SrTiO3 and LaAlO3, both insulating oxides.  
In this paper, the recent developments of oxide thin film growth 
and future challenges in the field of oxide electronics are addressed.  
 
 
Oxide materials start to play a very important role in electronic devices. 
Nowadays, it is possible to control the electronic properties of these materials with 
nanoscale precision [1, 2, 3]. This class of oxide compounds with perovskite type 
crystal structure exhibit a broad range of functional properties, such as high 
dielectric permittivity, piezoelectricity and ferroelectricity, superconductivity, 
colossal magnetoresistance and ferromagnetism. Many of these phenomena occur 
in perovskite oxides that are lattice-matched within a few percent of one another. 
This enables fabrication of heteroepitaxial structures, in which the multiple 
degrees of freedom can be accessed, making a myriad of devices with novel 
functionalities possible [4]. The properties of oxide interfaces in such 
heterostructures can be exploited for applications in electronic devices. Specific 
oxide devices relying on interface properties have already been realized and 
employed, such as Josephson junctions and SQUIDs, magnetic tunnel junctions 
based on manganites and FeRAMS. However, a completely new class of (nano) 
devices can be envisaged and engineered exploiting the functional properties of 
oxides. A real breakthrough in this field can be obtained by controlling and 
tailoring the physical properties at the interfaces between different oxide materials. 
Interfaces and surfaces in such highly correlated systems offer far more 
application possibilities than interfaces involving only conventional metals and 
semiconductors, but are more complex. Interfaces alter the bulk electronic system 
sometimes with dramatic consequences; interfaces break the translational and the 
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rotational symmetry, induce stress or strain, consequently altering the distances 
and bonds between the ions, giving rise to shift and distortion of the electronic 
states and energy levels and modifying the bands. By altering the electronic states, 
interfaces modify also electronic correlations. Because the correlations control the  
electronic behaviour of the material, their modification can induce remarkable 
changes of the collective electronic and magnetic properties. 
The strong interplay of the crystal degree of freedom as well as the correlated 
character of electronic behaviour in perovskites allows for new microscopic 
physical mechanisms as well as new macroscopic physical properties. This is, for 
instance, best illustrated by recent work by Harold Hwang and our Laboratory [1, 
5] on interfaces between epitaxial heterostructures of SrTiO3 and LaAlO3, both 
band insulators. In Figure 1, a schematic view and cross-section transmission 
electron micrograph (TEM) are shown of a SrTiO3/LaAlO3/SrTiO3 
heterostructure, fabricated by pulsed laser deposition (PLD). Reflection high-
energy electron diffraction (RHEED) is used to control the growth, which provides 
heterostructures with sharp interfaces. Because of the valence discontinuity at the 
interface, electronic reconstruction takes place between the two insulating oxides 
which gives rise to conductivity at the interface. To understand this interface 
activity, it is instructive to describe the perovskites in terms of their constituting 
AO and BO2 layering sequence. For example, whereas the two band insulators 
SrTiO3 and LaAlO3 are seemingly similar, the SrO and TiO2 layers are charge-
neutral, while the charge states in the LaAlO3 are (LaO)+ and (AlO2)-, respectively. 
In heterostructures, the AO-BO2 stacking sequence is maintained, and 
consequently a polarity discontinuity arises at the LaAlO3-SrTiO3 interface. It has 
been shown [1] that due to this, the LaO:TiO2 interface becomes conducting, with 
the conduction governed by electron-transfer from LaAlO3 into the TiO2 bonds of 
the SrTiO3. At the AlO2:SrO interface the AlO2 acts as an electron acceptor, 
resulting in a p-type interface. Such conducting interfaces are analogous to two-
dimensional electron (hole) gasses (2-DEGs) in semiconductors, which find 
                    (a)     (b)         
 
Figure 1: Schematic view of a SrTiO3/LaAlO3/SrTiO3 heterostructure (a) Cross section 
high-angle annular dark field (HAADF) TEM image of the LaAlO3/SrTiO3 
superlattice along the [001] zone axis (b). 
 
SrTiO3 
LaAlO3 
SrTiO3 
Integrated Micro Nano Systems 
 43 
applications in e.g., opto-electronic, high-power RF and magnetoelectronic 
devices. This example  
 
 
shows that perfect control of the atomic stacking at interfaces between perovskite 
oxides allows for tuning of the electronic structure of such interfaces.  
The application of epitaxial1 oxide thin films in devices, relying on multilayer 
technology, requires (atomically) smooth film surfaces and interfaces. 
Understanding of the different mechanisms affecting the growth mode is, 
therefore, necessary to control the surface morphology during thin film growth.  
The fabrication of epitaxial complex oxide thin films involves deposition as 
well as subsequent growth. Here, growth is the incorporation of the adsorbed 
atoms (adatoms) at the film surface. Many surface processes during deposition and 
growth determine the thin film properties such as crystallinity in-plane residual 
stress and surface morphology and are, therefore, subject to in many studies. 
Reflection high-energy electron diffraction (RHEED) is most often used to study 
the mechanisms and film surface processes during growth, whereas scanning 
probe microscopy (SPM) is usually employed to study the surface morphology 
after deposition. 
Frequently, physical vapour deposition (PVD) techniques, such as sputter 
deposition, molecular beam epitaxy (MBE) and pulsed laser deposition (PLD), are 
used for the fabrication of thin films. Among these techniques, PLD has emerged 
as a unique method to fabricate epitaxial and nearly single crystalline thin films of 
complex oxides, such as superconducting high-Tc cuprates, metallic, ferroelectric, 
ferromagnetic, and dielectric oxides. Conceptually and operationally, PLD is a 
simple technique. A pulsed, highly energetic laser beam is focused on a target, 
resulting in ablation of material. This material is deposited on a substrate, placed 
opposite to the target, resulting in thin film growth.  
                                                 
1
 In epitaxial growth, a film with preferred crystallographic orientation is formed on a 
crystalline surface as the result of deposition of material onto that surface. 


Figure 2: Schematic view of pulsed 
laser deposition with RHEED. The 
black line represents the trajectory of 
the laser beam. With every laser pulse, 
material is evaporated from a target and 
deposited on a substrate. With RHEED, 
the growth of this material can be 
controlled on an atomic level. 
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A unique feature of PLD is the modulated deposition. Short pulses (~100 µsec) 
with high deposition rate are alternated by a relatively long interval where no 
deposition takes place. Because of the instantaneous deposition, the two basic 
processes, i.e., random deposition and growth through rearrangement are separated 
in time, which is unique for PLD. Since the diffusivity is directly coupled to the 
surface properties, i.e. structural, chemical and physical, these can be studied 
during the initial growth. A good example is the observed self-organized 
conversion [6] of the terminating atomic layer from RuO2 to SrO during the initial 
growth of the ferromagnetic oxide SrRuO3 on TiO2-terminated SrTiO3. This 
conversion induces an abrupt change in growth mode from layer-by-layer to 
growth by step advancement, indicating a large enhancement of the surface 
diffusivity. This growth mode enables the growth of single crystalline and single 
domain thin films. We have shown that both conversion and resulting growth 
mode enables control of the interface properties in heteroepitaxial multilayer 
structures on an atomic level. 
To summarize, perovskite (ABO3) oxides, interfaces and epitaxial 
heterostructures of these oxides exhibit a large amount of exceptional physical 
properties, providing the basis for novel concepts of oxide-electronic devices. For 
a given parent compound, a rich phase diagram is coloured-in by substitution of 
the A or B cations, and/or a change in the oxygen stoichiometry. The ionic 
character of the chemical bonds and the consequent possibility of electronic 
reconstruction often render interfaces in these materials strongly electronically 
active. These remarkable interface characteristics even increased the interest in 
these materials, especially in the field of conducting interfaces and artificial 
multiferroics. Perfect control of the crystalline structure, chemical bonding and the 
phase formed at the interface are a prerequisite to access the mentioned multiple 
degrees of freedom. However, there are many open questions which will be 
addressed by research groups in the near future. These questions relate to the 
following topics: 
 
• the atomistic initial growth processes during heteroepitaxial growth; 
• control of the interface structure, i.e., crystallinity and atomic stacking 
sequence; 
• the relation between the interface structure and physical properties, such as 
electronic structure; 
• the relation between the electronic structure of the growth surface and 
initial growth behaviour. 
Furthermore, increasing trends in the field of oxide electronics are observable. 
These are, amongst others: 
• Materials by design; theoretical and computational work will drive the 
experimental groups to “design” materials with enhanced or new 
properties; 
• Complex oxide heterostructures will be integrated with silicon technology. 
Integration of these technology platforms will enable devices with new 
functionalities. An example is the emerging field of piezo-MEMS 
technology; 
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• Major facilities (such as the ESRF in Grenoble) will play a important role 
in characterization. 
To conclude, the application of complex oxides in electronic devices will 
enable new possibilities, provided that the fabrication can be performed with 
atomic precision. Recent progress in fabrication technologies enables researchers 
to obtain this precision and an even greater progress can be expected in the active 
research field of oxide electronics in the near future. 
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The University Twente, the local Province Overijssel and a group of five private 
investors have agreed to work together in a public-private partnership to 
commercialize inventions at the micro- and nanotechnology research institute 
MESA+. This partnership will take the legal form of a private limited company 
with the name “MESA+ International Ventures” (MIV).   
Micro- and nanotechnology are promising new technologies that have the 
potential to revolutionize existing industries with new products and services. Due 
to the high-tech multidisciplinary character and sometimes disruptive impact, 
implementing micro- and nanotechnology is difficult without the right partners 
and environment. Having MIV based around MESA+, which is specifically 
designed for micro- and nanotechnology-based solution platforms, brings together 
the right partners, environment and approach to successfully scout and implement 
micro- and nanotechnology. 
 
 
Screening technologies for market potential 
 
MIV will work with the MESA+ scientists to identify and rank technologies that 
may have commercialization potential. To this end, a screening tool is used to give 
scores to individual technologies. The screening tool takes various commercial 
aspects of a given technology into account such as potential market size and 
growth expectations, potential profitability, time to market and the anticipated 
costs to produce a technology demonstrator (prototype) and an end product, the 
estimated probability of success, the intellectual property rights (IPR) and last but 
not least whether enough relevant man power will be in place for the forthcoming 
period to be able to develop the technology towards a product of service.  
 
 
Developing the technology towards the markets 
 
Developing the technology is only one part of the equation, but in order to really 
reap the economic fruits of the technical developments, they must be - after having 
been identified as potentially commercially viable - marketed with vigour. Once a 
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technology has been identified as potentially commercially interesting, the actual 
successful commercialization starts with a process that addresses:  
• securing the necessary intellectual property rights; 
• conducting market analyses to understand the market and the players in 
terms of potential customers, partners, competitors and suppliers of a 
particular technology;  
• approaching potential off-takers to determine with them the exact 
specifications of a particular product and/or application that is based on the 
MESA+ technology; 
• pushing the technology forward according to market demands (from the 
lab table to a technology demonstrator or prototype); 
• determining the optimal distribution strategy for a given technology; and 
• identifying at least one lead customer who needs to be convinced to show a 
keen interest in the product and/or application at hand.  
These elements are embarked upon within a so-called “stealth project”. Thus, once 
a particular technology has been initially scored and ranked as interesting from a 
market and financiers’ perspective, the scientists are invited to work together with 
MIV in a stealth project. The term “stealth” has been introduced, because the 
project will not be embedded within a dedicated limited company at the very start 
of the project.  
Whereas in general the chances of a commercial success for an (early stage) 
technological discovery are substantially less than 50%, the actual incorporation of 
a company is postponed and the purpose of the stealth project is to enhance the 
overall probability of success of commercially exploiting a technology such that a 
thorough, financially attractive proposition can be made to the markets on which 
basis venture capital can be mobilized and a MESA+ spin-out company can be 
initiated. In case the technology would eventually prove not to be commercially 
interesting enough, the stealth project can be silently aborted without having to 
liquidate a company.  
Albeit not a company in the legal sense, every stealth project will be run as a 
virtual company under the MIV umbrella. The stealth project will get its own 
virtual balance sheet, virtual profit and loss account and a dedicated budget. A 
project manager will be assigned to the project and the people working on a 
particular stealth project will experience this as if they were already part of a 
dedicated company. In this way, scientists will get commercial experience and 
exposure.  
For each stealth project, MIV will enter into a contract with the scientists 
involved. This contract covers the basis on which the scientists will participate in 
and work with MIV on a stealth project and it covers the future role of the 
scientists in the spin-out company, were it to emerge. In the same contract, MIV 
agrees with the scientists how future revenues will be split.  
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Spinning out 
 
Once the specifications that are demanded by the market are clear and the 
necessary IPR (patents) have been secured, once potential customers have been 
identified, approached and persuaded to show commitment on a certain product or 
application and once the market size and distribution strategy has been 
determined, an investment case can be presented to the financial community such 
to spin out a dedicated venture with the highest possible probability of success. 
The preparation of a convincing business plan, determining the optimal legal and 
fiscal structure for a spin-out and the selection of and contacting of private 
investors are other tasks of MIV.  
Private investors include categories such as venture capitalists and corporate 
venture organizations. MIV will negotiate with or on behalf of the scientists 
involved what terms and what share percentage will be offered to the private 
investor(s) in return for a financial injection. Moreover, together with the 
interested private investor(s), MIV will also identify and prepare a proposition to a 
future chief executive officer (CEO) of the aspired spin out. The initialization of a 
spin-out company completes MIV’s tasks.  
It is the aim that MIV will initiate two to three stealth projects per year and it is 
expected that a stealth project will run for a period of approximately two years. In 
the third year after MIV has started, the first spin-out company is anticipated. MIV 
will become self-funded once exit money from selling shares in spin-out 
companies becomes available. 
By so doing, MIV and the scientists involved bridge the gap between 
technology and markets and put in place a strategy and a dedicated vehicle that 
enhance the chances of success for the commercialization of a particular 
technology from the day that the technology emerges. 
The mission, vision, strategy and goals of MESA+ International Ventures are 
summarized in Figure 1 below. 
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Figure 1 MESA+ International Ventures 
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Introduction 
 
The continuously rising costs in healthcare, the growing size of the aged popula-
tion who will need healthcare services, and the rise of expectations regarding the 
quality of healthcare services all create a high need for new approaches to reduce 
healthcare costs while maintaining or even increasing the level of service. At the 
same time recent developments provided by bio-, micro- and nano-technologies 
create new opportunities for realizing innovative healthcare services. By the use of 
these new technologies in healthcare different goals are in the focus: To decrease 
overall costs for healthcare, to improve healthcare quality, and to collect and 
consolidate patient-related information from different devices and sources. 
However, this raises many challenges ranging from core technical issues (e.g., 
secure integration and processing of medical data from small, unobtrusive devices) 
to the more application-oriented issues (e.g., realization of new healthcare services 
and treatment scenarios). 
To actively contribute to these goals, the Centre for Telematics and Information 
Technology (CTIT) at the University of Twente has selected E-health as one of its 
strategic research orientations (SRO). The aim of this SRO is to investigate the use 
as well as the further development of advanced information and communication 
technology (ICT) in the healthcare chain. Obviously, this necessitates 
multidisciplinary research, which not only considers technological issues but 
addresses legal and societal aspects, too.   
So far, activities of the E-health SRO have been focused around topics such as 
mobile health services, ambient computing and IT support for healthcare 
processes. Considering the current trend towards miniaturization (e.g., realization 
of small, unobtrusive medical devices collecting data from a patient or medical 
implants supporting the medication of a patient) new challenges as well as new 
perspectives with respect to these topics arise. Researchers from the E-health SRO 
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are aware of this fact and want to contribute to converge bio-, micro- and nano-
technology towards integrated smart medical systems.  
 
Participating Research Groups and Partners 
 
Research activities of the E-health SRO have been interdisciplinary from the very 
beginning and have involved groups from different disciplines including Computer 
Science, Management Science, Mathematics and Behavioral Sciences. An 
overview of the research groups currently participating in the SRO is depicted in 
Table 1.  
In order to deal with the trends and challenges described in the introduction, in 
future, partners with strong competence in bio-, micro- and nano-technologies will 
also be involved in projects of the SRO. The overall objective is to contribute to 
the development of integrated bio-, micro- and nano systems in healthcare, and 
thus to enable innovative healthcare services.  
 
 
EWI-ASNA Architecture and Services of Network Applications 
EWI-CADTES Computer Architecture Design & Test for Embedded 
                            Systems 
EWI-DIES Distributed and Embedded Systems 
EWI-HMI Human Media Interaction 
EWI-IS Information Systems 
EWI-SK Statistics and Probability 
EWI-SOR Stochastic Operations Research 
EWI-DMMP Discrete Mathematics and Mathematical Programming 
EWI-BSS Biomedical Signals and Systems 
BBT-OMPL Operational Methods for Production and Logistics 
BBT-ISCM Information Systems & Change Management  
BBT-CSST Centre for Studies of Science, Technology and Society  
BBT-STePHS  E-health Architecture and Standards (part of       
                            BBT/STePHS) 
Table 1: Research groups participating in the E-health SRO (July 2006) 
In their e-health related research projects these groups have already cooperated 
with partners from both industry and healthcare. Table 2 shows selected partners 
actively involved in current projects.  
 
 
 
Integrated Micro Nano Systems 
 52 
Partners from industry  
Atos Origin, Ericsson, IBM, Lucent Technologies, Ortec, Philips Medical 
Systems, Philips Research, Roessingh R & D, Telematica Instituut, TNO, 
Twente Medical Systems International, Vodafone, Yucat  
Partners from the healthcare domain 
Amsterdam Medical Centre, Erasmus Medical Centre,  ESG, 
Medisch Spectrum Twente,  Hospital Clinic i Provincal de Barcelona 
(HCPB), Lito Polyclinic Paralimni LTD,  University of Marburg 
(Medical Informatics Group) 
 Table 2: External research partners of the E-health SRO (July 2006) 
Finally, the E-health SRO actively participates in several Dutch initiatives in the 
healthcare domain including the IZIT program of the Province of Overijssel, the 
Dutch HL7 group and the ESIH group on emerging standards in healthcare. 
 
 
Current and Future Research 
 
The overall objective of the E-health SRO is to develop innovative ICT services 
for improved and integrated care. Along this line researchers of the E-health SRO 
cover various topics including telemedicine, smart medical surroundings, process 
and information management in healthcare, privacy and security in healthcare, 
bioinformatics, and user-centered design of healthcare ICT services.  
Research is focused around four major themes: telemedicine and mobile health 
services, smart medical surroundings, optimization and IT support of healthcare 
processes and bioinformatics. In the following we sketch related scenarios and 
relevant issues. 
 
Telemedicine and Mobile Health Services  
By 2020, roughly 25% of the population in the western world will be aged 60 or 
older. With age, we increasingly suffer from chronic health problems which limit 
our activities in daily life. It is a challenge to use technology to support the quality 
of life of these chronically impaired people. Care for these persons is best 
provided in the home environment. Care is about quality of life, where cure is 
about saving life. 
Chronically ill people, or those living with a condition which needs regular 
monitoring, are often limited in daily life activities and not free to do spontaneous 
things. Their regime is planned around hospital visits, check-ups and overnight 
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stays. In many cases, patients feel insecure at the thought of being away from 
medical attention, anxious that it would be too risky for their health.  
The forthcoming availability of high bandwidth public wireless networks and 
emerging technologies for equipping people with sensors interconnected within a 
body area network will provide new opportunities to significantly improve this 
situation. In this context, SRO researchers have been developing new mobile 
healthcare services. For example, these services enable the contactless monitoring 
of patients or the automatic detection of emergency situations. From the 
introduction of such services into healthcare practice we expect healthcare 
professionals to be able to remotely access, diagnose and treat patients whilst these 
patients are free to continue with normal daily life activities.   
 
Smart medical surroundings  
Treatment procedures which were previously confined to the hospital will 
increasingly be provided in the home environment. Accompanying this trend, 
patients will in future be surrounded by “intelligent” electronic equipment that 
can satisfy information and communication needs on demand. Researchers from 
the E-health SRO investigate, define, and develop core architectures and 
frameworks to underpin such ambient intelligent environments. Research themes 
centre on the development of new devices (sensors, actuators, special hardware) 
and networking capabilities (e.g. wireless), but also address the more software-
oriented and application-related issues (e.g., requirements engineering). A typical 
demonstration scenario on which SRO researchers are working is the provision of 
smart agents to automatically collect patient data during homecare. Besides 
homecare there are a variety of other challenging application scenarios for smart 
health surroundings including well-being (sports and fitness) or the support of 
healthcare professionals in daily life and work.  
In both areas – mobile healthcare services and smart medical surroundings – the 
E-health SRO not only deals with issues related to core technology, but takes a 
business process viewpoint as well. The introduction of mobile devices into 
healthcare practice, for example, requires the solution of technical problems such 
as security, privacy and reliability of services offered by those devices. However, 
these solutions can only work in practice if they align with the business processes 
employing these devices, and if these processes themselves are redesigned to work 
effectively with these devices. In this context one has to consider that the 
healthcare sector is characterized by complex but nevertheless highly structured 
interactions between different user groups, including health care professionals 
(doctors and nurses), patients, vendors of medical technology and medical 
information systems and health insurance companies. A thorough understanding of 
these interactions is needed to anticipate the factors that facilitate or complicate 
the acceptance of, or potential negative attitudes towards, the new technology. (In 
the past many technological innovations in the healthcare sector failed because 
user needs had not been taken into account!).  
Integrated Micro Nano Systems 
 54 
Even more ambitious is the introduction of ambient technology such as wireless 
body area networks for health monitoring. Apart from the difficult technical 
problems in making these devices communicate securely and reliably, we need to 
redesign health care procedures to work effectively with them. Moreover we must 
align these devices and procedures with the patients’ way of living as well. 
Though Smart medical surroundings are user-centered technologies, no systematic 
research has been done on the preferences and skills of users in the healthcare 
sector with respect to this new technology. Again this necessitates multi-
disciplinary research to investigate and assess the needs and interests of the 
different stakeholders and users in the healthcare sector.  
Another challenging issue concerns the integration of medical data produced or 
consumed by the respective devices. Integrating data, devices and the services 
provided by them is a difficult task, as individual systems have usually not been 
designed to cooperate. In particular, respective solutions are often based on 
differing conceptualizations of the application domain, which are not necessarily 
compatible. Today powerful integration tools (e.g. different kinds of message-
oriented middleware) are available to overcome technical and syntactic 
heterogeneity of autonomous system components (e.g., medical devices). Yet, 
semantic heterogeneity remains as a major barrier to seamless integration of 
autonomously developed software devices and smart medical systems.  
 
Optimization and IT support of processes in healthcare 
Patterns of healthcare provision are increasingly changing from isolated treatment 
episodes towards a continuous treatment process involving multiple healthcare 
professionals and various institutions. For integrated care, process and information 
management play a crucial role in this interdisciplinary process.  
In particular, patient treatment requires the cooperation of various healthcare 
providers and medical disciplines. Thus optimized and coordinated process 
support play a crucial role in healthcare in order to improve the quality of patient 
treatment and in order to decrease costs. Groups from the E-health SRO are 
working on different topics related to healthcare processes. One focus is on the 
provision of methods and models for process and resource optimization. This 
includes, for example, support for the planning, scheduling and benchmarking of 
operating theatres or for the simulation of emergency scenarios. Another focus is 
on the IT support of patient treatment processes in both healthcare organizations 
and healthcare networks. Topics of interest include the implementation of medical 
guidelines and clinical pathways, the realization of lifetime patient records, the 
provision of patient information and medical knowledge at the point of care, the 
evolution of healthcare standards, and privacy and security issues. 
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Bioinformatics  
Bioinformatics will open new opportunities for healthcare as well. For example, 
the SRO participates in a project whose aim is to process bio-information from 
data to knowledge in such a way that its dissemination will provide enabling 
technologies and innovative methods to a multitude of educational, research-
related and developmental life science applications such as the provision of new 
lab tests in healthcare. 
Table 3 shows selected projects in which groups from the E-health SRO are 
currently involved.  
 
Project Name Funding Organization 
HealthService 24 – Continuous mobile 
services for healthcare 
EU / eTen 
Biorange – A research program to 
shape the future for bioinformatics in 
the Netherlands 
Bsik 
Privacy and the dynamics of network 
technologies in the healthcare sector 
NWO Netwerk voor Netwerken 
PROSE – Process Support in 
Healthcare 
NWO Hefboom 
NFU Operating Room benchmarking 
project 
NFU and all 8 Dutch Academic 
hospitals 
Smart Surroundings, 
WP Interfaces & Interaction / Setting 
Bsik Smart Surroundings (since 
2004) 
  
Privacy and the dynamics of network 
technologies in the healthcare sector  
NWO Netwerk voor Netwerken 
Multi-modal Visualization 
Environment for Interactive Analysis 
of Medical Data 
NOW 
MinADEPT – Mining of adaptive 
healthcare processes  
NWO Open Competition 
AWARENESS – Context AWARE 
mobile Networks and ServiceS / 
Personal Treatment Services 
Bsik Freeband (since 2004) 
Table 3: Selected Projects of the E-health SRO started in 2004 or 2005 
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Summary and Outlook 
Supporting the quality of daily life of patients can be approached in two ways. One 
is to use technology to restore lost or damaged function (e.g., provide an electrical 
stimulator to a paralyzed person). The other is to adapt the environment of the 
client so that the loss of a function does not create a problem anymore. This has 
traditionally been the domain of rehabilitation, where assistive technologies have 
been used in these two approaches.  
The second approach would fit ideally in a smart medical surroundings 
initiative. There is the challenge in designing new mobile healthcare services and 
smart medical surroundings technologies that can support the quality of life of 
chronically impaired citizens in a modern affluent information society. These 
citizens don't want a computer on their table. They want their problems to be 
alleviated with technologies that seamlessly fit in their daily environment and 
daily tasks. In this context we could build on the experience obtained in 
rehabilitation. There we see the difficulties of using technologies in this area. 
Roughly 30-50% of technologies prescribed have been abandoned by the users 
after some time. This is a shameful waste of resources - something is going 
terriblly wrong in the design and/or prescription process. Therefore assessment of 
user needs and fears must be an important part of any research in this context. 
Furthermore, chronically impaired people all have specific individual problems. 
It is not trivial to design a platform technology that can be tailored to the needs of 
the individual client. Care is something that cannot be provided by machines - 
interaction with people is vital. This means that innovative care services will need 
to be developed that provide added value over what we have until now. 
There are ethical questions as well. We should take care that technology does 
not create social isolation of people who are already vulnerable in this respect. 
Ideally, this technology should support social and societal participation. 
Surely ICT has the potential to do this, we "only" have to exploit this potential.  
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Collaboration between the Institutes 
 
This Symposium on Integrated Micro Nano Systems brought together researchers 
from the University of Twente who are working in different disciplines and 
different institutes: CTIT (Centre for Telematics and Information Technology), 
MESA+ (Institute for Nanotechnology) and BMTI (Institute for BioMedical 
Technology). The symposium has raised many R&D challenges and has given 
insights into new solutions for next generation application services and products 
based on bio-, micro- and nano-technologies. From the different presentations it 
has become obvious that healthcare constitutes a key application in this context, 
perhaps even supplying the killer application for these new technologies. Future 
innovation and progress will necessitate close cooperation between these groups 
and the further strengthening of multidisciplinary research. The three institutes 
(CTIT, MESA+ and BMT) agreed to explore collaboration possibilities and to 
organize follow up events in future. 
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Demonstrations and posters 
 
 
 
 
Body Area Networks for health 
 
 
Bert-Jan van Beijnum, Richard Bults 
 
Centre for Telematics and Information Technology, University of Twente 
 
 
In this demonstration we show one variant of the health BAN developed by the 
University of Twente and partners during the projects MobiHealth, Awareness and 
HealthService24. 
Here the MBU (Mobile Base Unit) is realised on a Qtek PDA and the sensor 
devices demonstrated are pulse oxymeter (for measuring Oxygen saturation in the 
blood, displayed as a real time pulse plethysmogram trace) and temperature sensor 
(for measuring skin temperature). Heart rate can also be derived from the output 
off the pulse oxymeter and is displayed as a numeric readout on the BAN and on 
the screen. Biosignals can be viewed on the MBU and are also transmitted over 
GPRS or UMTS to be viewed remotely by a doctor or other healthcare 
professional. 
In IST MobiHealth many different configurations of the BAN were trialled on 
different patient groups; including trauma patients, pregnant women, cardiac 
patients and patients with respiratory insufficiency (Chronic Obstructive 
Pulmonary Disease). In FREEBAND Awareness the BAN is specialized for 
telemonitoring of epilepsy patients and patients with spinal cord lesions, and for 
teletreatment in chronic pain management. In eTEN HealthService24 the 
cardiology, COPD and pregnancy applications are further developed and we 
prepare for commercialisation of BAN-based m-health services. 
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Smart Signs System 
 
 
Maria Lijding 
 
Centre for Telematics and Information Technology, University of Twente 
 
 
In this demonstration we will present a simulation of the guidance functionality of 
the Smart Signs system. Smart Signs are a new type of electronic door- and way-
sign based on wireless sensor networks. Smart Signs present in-situ personalized 
guidance and messages, are ubiquitous and easy to understand. They combine the 
ease of use of traditional static signs with the flexibility and reactivity of 
navigation systems. The Smart Signs system uses context information such as 
knowledge of the user’s mobility limitations, the weather and possible emergency 
situations to improve guidance and messaging. Minimal infrastructure 
requirements and a simple deployment tool make it feasible to easily deploy a 
Smart Signs system on demand. 
 
 
http://wwwes.cs.utwente.nl/smartsurroundings/ 
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A portable instrument for point-of-care HIV monitoring 
in resource-poor countries 
 
 
Aurel Ymeti, Christian Breukers, Xiao Li, Bjorn Lunter and Jan Greve 
 
 
 
HIV infection is a major problem in many resource-poor countries. These 
countries usually have neither the means to buy antiretroviral drugs nor the 
equipment for staging HIV-positive patients. The affordability of drugs is now 
being improved due to joint efforts of governments and pharmaceutical 
companies. This stresses the need for affordable diagnostic monitoring methods 
that require relatively simple facilities and easy training of unskilled personnel. 
Treatment of HIV-infected patients requires knowing the number of the CD4+ 
T-cells (responsible for killing invading organisms such as viruses and bacteria) in 
the blood of the patients. Conventional western world technologies are too 
expensive for use in resource-poor countries. Therefore, we developed a method 
for point-of care CD4+ T-cell enumeration. In this method, whole blood is diluted 
with buffer and incubated with CD4-magnetic nanoparticles together with CD3-
fluorescent label. The sample is loaded in a chamber, which is inserted into a 
magnetic yoke. The magnetically labeled CD4 T-cells are collected at the upper 
surface of the chamber. An automated fluorescence microscope, StarCount, was 
built for detection of target CD4 T-cells. It has light-emitting diodes illumination, 
is fully computer-controlled and operates from a 12V battery. Tests on HIV-
infected patients show a good correlation with gold standard methods.  
A lab-on-a-chip instrument for point-of-care HIV monitoring is under 
development. 
Using microfluidics, different steps such as blood collection, mixing of blood 
sample with reagents, and discrimination of target cells will be further improved. 
Monitoring of malaria and tuberculosis, usually coexisting with HIV, can be easily 
implemented using the same instrument. 
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The Frontiers Technology Assessment Programme 
Multi-path mapping: integrating micro and nano tools 
within a single-cell analysis platform 
 
 
Douglas K. R. Robinson and Tilo Propp 
 
University of Twente & TA-NanoNed 
 
 
To be able to handle the many new challenges faced by modern science and 
technology R&D the Frontiers network of excellence will explore a number of 
issues relating to  
• organisation with respect to integration, research agenda coordination and 
strategy development; 
• Ethical Legal and Societal Aspects of new technologies (ELSA); and  
• the effect of images of nanotechnology on research agenda setting and 
policy. 
To enable substantial and a high standard of exploration of these important 
challenges, the Frontiers network of excellence includes scholars of socio and 
economic theories of technical change, technology and innovation studies and 
technology assessment. Together with other members of the network of excellence 
they will coordinate a number of Technology Assessment Projects.  The first three 
projects will each cover one of the points mentioned above based on a specific 
nanotechnology field or generic challenge. 
The first project deals with the challenge of integration of various micro and 
nano components, tools and techniques into a platform for further research 
purposes and perhaps for application in society (such as the medical sector, 
pharmaceutical sector etc.).  The subject topic is “towards an integrated cell 
analysis platform and beyond”.   
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Figure 1: Workshop session, 12th June 2006, De Rode Hoed, Amsterdam 
 
The process topic was how to deal with roadmapping and strategy articulation in 
an emerging field where the complex mix of varying and evolving research lines 
need to coordinate to enable an integrated analysis platform.  Together with 
representatives for the research sector, technology assessment and industry sectors, 
the Frontiers team will explore some of the issues involved with integrating a 
number of research lines, how to develop a roadmap but maintain flexibility to 
allow further research and integration of results from more fundamental research 
orientations. 
The output will was a multi-path roadmap of possible directions, a number of 
scenarios based on both work from the participants and analysis from the 
technology assessment scholars and a list of action points and recommendations 
for the Frontiers network (and more broadly to the European Research 
Community).   
For the topic itself, a better understanding of integrating different (often 
disciplinary diverse) research lines for a technology platform (such as a Lab-on-a-
chip) and a better understanding of the evolution of the field of micro and 
nanotools for integrated cell analysis was reached. 
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Figure 2.   Multi-path map of paths to applications 
 
 
 
For more information, please contact info@technologyassessment.info 
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Laser Interference Lithography for Nanostructured 
Surfaces 
 
 
Regina Luttge, Henk van Wolferen and Leon Abelmann 
 
MESA+ Institute for Nanotechnology, University of Twente, P.O. Box 217, 
7500 AE Enschede; The Netherlands 
Email: r.luttge@utwente.nl 
Homepage: http://www.el.utwente.nl/smi/ 
 
 
Keywords: Biocompatibility, nanopatterned surface, laser interference 
lithography, enabling nanotechnology, nanoarrays, nanofluidics. 
 
 
Objective 
 
The objective is fabrication of arrayed sub-100nm nanopatterns and study of their 
interactions with biological material (tissue, blood, viruses, proteins etc.). These 
nanostructured surfaces can by exploited as interfaces for biological and chemical 
sensor systems.  
 
Methods 
 
Laser interference lithography (LIL) operating a 266nm continuous laser source is 
utilized for pattern generation. Standard (100) prime silicon wafers were used. For 
LIL, we employ diluted Olin 907-13 and chemical amplified resist (CAR) being 
suitable to spin-coat a film thickness below 200nm. Both resist systems allow us to 
fabricate gratings, dots and even complex grayscale lithographic patterns at high 
resolution. 
 
Results 
 
We employed up to four multiple exposures with the photoresist subsequently 
being developed in a single step to generate Moire-type nanopatterns. Simpler 
nanograting and nanodot arrays were also fabricated to explore their surface 
behavior. Lithographic results and evaluation of droplet shape are depicted in 
Figure 1 below.   
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Figure 1. Lithographic results and evaluation of droplet shape 
 
(A) µl-sized water droplets on unpatterned glass. (B,C) µl-sized water droplets on LIL 
surfaces showing the ability to influence the shape of a droplet by the geometry of the 
nanostructure. Spreading of the larger droplet in (C) stops at the interface between two 
different patterns. (D) Typical LIL grating structure in resist. (E) Double exposure leading 
to dome shaped dots. (F) Four multiple exposures resulting in a spatially defined 3-D 
nanoarray throughout the exposure area of 2cm x 2cm using Olin. (G) 3-D nanostructure 
using CAR at a period of 150nm. (H) Double exposure using CAR leading to 3-D 
nanopattern in resist. (J) Same pattern as (H) after O2 plasma etching. 
  
 
Conclusions 
 
Two and three dimensional periodic surface patterns at the nanoscale can be 
generated employing 266nm-laser interference lithography. The photoresist 
material can be used to explore physical effects at nanofluidic interfaces as well as 
molecular biointeractions. 
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Engineering at the University of Twente in February 2004. He is the recipient of 
the 2003 Young Fluorescence Investigator award from the Biophysical Society. 
His research interests include protein conformational dynamics, protein misfolding 
in disease, and advanced technologies for imaging and spectroscopy. 
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Clemens van Blitterswijk graduated as cell biologist at Leiden University in 
1982. He defended his PhD thesis in 1985 at the same university (promoter, 
prof.dr. J.J. Grote), on artificial ceramic middle ear implants, for which he was 
rewarded the Jean Leray award, the Marie Parijs award and the Klein award in the 
following years. He continued his research on bone replacement primarily, with 
extensions to cartilage and skin substitution. 
Today most of his research deals with tissue engineering applications. Prof. van 
Blitterswijk has authored and co-authored over 200 scientific papers, guided 26 
PhD students as promotor or co-promotor, is inventor on numerous patents and 
frequently acts as invited speaker or chairman at international conferences. For his 
more recent work he received the George Winter award of the European society 
for Biomaterials and was appointed Fellow of Biomaterials Science and 
Engineering by the international liaison committee. 
He acts and has acted on numerous advisory organs relating directly to life- and 
material sciences or to the economic applications thereof and held positions such 
as chairman of the Dutch society for Biomaterials and treasurer of the European 
Society for Biomaterials. 
During his career Prof. van Blitterswijk has co-founded four biomedical 
companies and held several functions in these organizations. He acted as CEO of 
IsoTis (a public life sciences company in the Netherlands) from 1996 to 2002. In 
total he raised over 120 Million Euros in funding through equity and/or grants. 
Resulting from his work 10 implant technologies were brought into clinical 
evaluation in humans.  
Today Prof. Van Blitterswijk has an appointment at Twente University in the 
Netherlands where, as Professor of Biocompatibility, he heads a team of PhD 
students active in the field of tissue engineering.  
 
 
Paul Nederkoorn studied Chemistry (cum laude), Medicinal Chemistry (cum 
laude) and Dutch Business Law. He wrote his doctorate thesis on the activation 
mechanism of the G protein-coupled histamine H2 receptor. Paul was a university 
lecturer and research group leader of computational medicinal chemistry at the 
Vrije University of in Amsterdam. He was awarded several scientific prizes 
including the Unilever Research Prize. In 1997 he joined Shell and held several 
positions in the Exploration & Production (EP) business unit including that as 
economics advisor, business opportunity co-ordinator and portfolio advisor. After 
a management buy-in with the involvement of two venture capitalists, Paul 
became the managing director of a Dutch data communication firm. In this 
capacity, he managed a turn-around of the company and concluded several 
framework contracts with national telecoms and a licence agreement with one of 
the leading Chinese telecom equipment manufacturers. Paul has acted as an 
advisor to several European venture capitalists, asset managers and M&A 
boutiques. Since October 2005, he has been assigned as the managing director for 
MESA+ International Ventures, a business development outfit for nanotechnology 
that has been developed at the University Twente.  
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Kees Eijkel is CEO of Kennispark Twente, an organization that is responsible for 
commercialization and related area development in Kennispark, which combines 
the University of Twente Campus and the adjacent Business and Science Park. 
This includes the development of lab and office infrastructure, patenting and 
technology transfer activities and business development. As director of the 
University Holding he manages the university’s participations. Kennispark is a 
joint effort of the Province of Overijssel, the University of Twente and the City of 
Enschede. The university already has a strong spin-off production, with 
approximately 600 firms started over the past 2 decades. Over the previous 7 
years, Kees was technical-commercial director of MESA+, the 450-person 
nanotechnology institute of the University of Twente, being responsible for 
facilities, internal affairs and commercialization. MESA+ has an integral turnover 
of over 50 Meuro and has generated 33 micro/nano spin-offs over the past 2 
decades. 
He is board member of two non-profit foundations supporting 
commercialization and education in micro/nano in the Twente region. He is CEO 
of MTF Ltd, which develops offices and labs, focused on further development of 
the regional commercialization strength. Currently, he is president of the Micro an 
Nanotechnology Commercialization Education Foundation MANCEF.  
He is co-architect of the 250 Meuro Dutch Nanotechnology Initiative. He is 
responsible for the nano-chapter in the Dutch Foreign Trade Minister's trade 
mission to Silicon Valley in January 2004 and Boston in September 2005. He was 
speaker, keynote and/or session chair in a large number of international 
conferences, with emphasis on conferences addressing the commercialization 
issues around scientific research.  
 
 
Manfred Reichert holds a Ph.D. in Computer Science and a Diploma in 
Mathematics. Currently, he is working as Associate Professor in the Information 
Systems Group at the University of Twente (UT). At UT he is also coordinator of 
the E-health SRO (Strategic Research Orientation) and member of the 
management team of the Centre for Telematics and Information Technology 
(CTIT), which is the largest ICT research institute in the Netherlands (with more 
than 400 researchers). Before Dr. Reichert joined UT in October 2004, he was 
working as Assistant Professor in the Department Databases and Information 
Systems at the University of Ulm (Germany). There he also finished his Ph.D 
thesis on adaptive process management in July 2000 (with honours). Dr. Reichert 
is an expert in the field of business process management in general and e-health 
processes in particular. He has initiated and managed numerous research projects 
in these fields, contributed numerous papers to these areas, and received several 
awards for his work. Before his University career, he was working for several 
years in the IT department of a large hospital and as an IT consultant.   
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